A biologic role for the 72-kDa gelatinase A (matrix metalloproteinase 2; MMP-2), beyond simple extracellular matrix turnover, was evaluated in glomerular mesangial cells. To determine the significance of MMP-2 secretion for the acquisition of the inflammatory phenotype, we reduced the constitutive secretion of MMP-2 by cultured mesangial cells with antisense RNA expressed by an episomally replicating vector or with specific anti-MMP-2 ribozymes expressed by a retroviral transducing vector. The phenotype of the transfected, or retrovirally infected, cells was profoundly altered from the activated state and closely approximated that of quiescent cells in vivo. The prominent differences included a change in the synthesis and organization of the extracellular matrix, loss of activation markers, and a virtually total exit from the cell cycle. Reconstitution with exogenous active, but not latent MMP-2, induced a rapid return to the inflammatory phenotype in vitro. This effect was specific to MMP-2, because the closely related MMP-9 did not reproduce these changes. Furthermore, this pro-inflammatory effect of MMP-2 is dependent upon the active form of the enzyme, which can be produced by an autocatalytic activation process on the mesangial cell plasma membrane. It is concluded that MMP-2 acts directly upon mesangial cells to permit the development of an inflammatory phenotype. Specific inhibition of MMP-2 activity in vivo may represent an alternate means of ameliorating complex inflammatory processes by affecting the phenotype of the synthesizing cells, per se.
A biologic role for the 72-kDa gelatinase A (matrix metalloproteinase 2; MMP-2), beyond simple extracellular matrix turnover, was evaluated in glomerular mesangial cells. To determine the significance of MMP-2 secretion for the acquisition of the inflammatory phenotype, we reduced the constitutive secretion of MMP-2 by cultured mesangial cells with antisense RNA expressed by an episomally replicating vector or with specific anti-MMP-2 ribozymes expressed by a retroviral transducing vector. The phenotype of the transfected, or retrovirally infected, cells was profoundly altered from the activated state and closely approximated that of quiescent cells in vivo. The prominent differences included a change in the synthesis and organization of the extracellular matrix, loss of activation markers, and a virtually total exit from the cell cycle. Reconstitution with exogenous active, but not latent MMP-2, induced a rapid return to the inflammatory phenotype in vitro. This effect was specific to MMP-2, because the closely related MMP-9 did not reproduce these changes. Furthermore, this pro-inflammatory effect of MMP-2 is dependent upon the active form of the enzyme, which can be produced by an autocatalytic activation process on the mesangial cell plasma membrane. It is concluded that MMP-2 acts directly upon mesangial cells to permit the development of an inflammatory phenotype. Specific inhibition of MMP-2 activity in vivo may represent an alternate means of ameliorating complex inflammatory processes by affecting the phenotype of the synthesizing cells, per se.
The complex interactions of cells with their surrounding extracellular matrix (ECM) 1 are critical determinants of multiple cellular properties, including the ability to divide, migrate, and differentiate. These highly integrated cellular features play major roles in the manifold processes governing angiogenesis, in tissue remodeling following injury, and in the ability of cancerous cells to invade and metastasize (Brenner et al., 1989; Liotta et al., 1991; Chen, 1992) . In addition to their extensive matrix protein synthetic repertoire, cells synthesize a broad array of variably specific enzymes required for the physiologic turnover of ECM proteins within the extracellular space. Recently, considerable attention has been focused on the role of the matrix metalloproteinases (MMP) in these events, with a particular emphasis on the ability of these enzymes to facilitate tumor invasion and metastasis (Mignatti and Rifkin, 1993) . The MMPs belong to the collagenase gene family and are characterized by secretion in latent, proenzyme form, dependence on zinc, and neutral pH for activity in the extracellular space and inhibition by the low molecular weight proteins, TIMP-1-TIMP-3 (Woessner, 1991) . The primary functional roles of the MMPs are generally considered to be the basal turnover of ECM proteins, including Types IV and V collagens, fibronectin, and laminin. In addition to facilitation of tumor progression, the augmented expression of MMPs in various inflammatory pathologic states, such as rheumatoid arthritis, is postulated to contribute to tissue injury, while suppression is believed to result in matrix protein accumulation and sclerosis (Kenyon, 1988; Okada et al., 1989; Firestein and Paine, 1992; Edwards et al., 1987; Kerr et al., 1988) . In marked contrast to this emphasis upon MMP interactions with the ECM, there has been little consideration of the effects of the MMPs on the synthesizing cells, per se.
The intrinsic glomerular mesangial cell is centrally involved in both the acute inflammatory and chronic sclerotic processes characteristic of many forms of glomerular disease (Sterzel et al., 1982; Sterzel and Lovett, 1988; Davies et al., 1990 Davies et al., , 1992 . We have recently demonstrated a close temporal linkage between mesangial cell activation (augmented proliferation and synthesis of ECM proteins) and the enhanced secretion of the 72-kDa gelatinase A (MMP-2) in a model of immune complexmediated glomerulonephritis Marti et al., 1994) . The linkage between cellular activation and enhanced MMP-2 expression suggested that a primary action of this enzyme may be a direct effect upon the cells, with subsequent induction of the inflammatory phenotype. Using cultured mesangial cells, which accurately replicate the inflammatory phenotype described in vivo, we demonstrate that antisense RNA or ribozyme-mediated reduction in MMP-2 synthesis leads to the restoration of the non-inflammatory, quiescent phenotype characteristic of the normal glomerular mesangium. Furthermore, this pro-inflammatory effect of MMP-2 is dependent upon the active form of the enzyme, which we demonstrate can be produced by an autocatalytic activation process on the mesangial cell plasma membrane.
MATERIALS AND METHODS

Establishment of Cells; Quantitation and Characterization of MMP
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1 The abbreviations used are: ECM, extracellular matrix; MMP, matrix metalloproteinase; MC, mesangial cell; bp, base pair(s); nt, nucleotide(s); PBS, phosphate-buffered saline; PCNA, proliferating cell nuclear antigen; PCR, polymerase chain reaction; TIMP, tissue inhibitors of metalloproteinases. screened for high level, constitutive secretion of the 72-kDa gelatinase A (MMP-2) using a quantitative [ 3 H]gelatin assay (Martin et al., 1989) . To obtain clones in which the only gelatinolytic activity was due to MMP-2, the serum-free conditioned media were analyzed by gelatin zymography. MC plasma membrane-enriched fractions were prepared by sucrose gradient centrifugation as reported (Lovett et al., 1987) , and gelatinolytic activities determined as above. The selected clones did not synthesize plasminogen activators, as determined by zymographic and immunologic analysis (rabbit anti-mouse urokinase plasminogen activator, cross-reactive with rat urokinase plasminogen activator; American Diagnostica, Greenwich, CT).
Growth rates of controls and antisense clones were determined by plating 5 ϫ 10 3 cells in 2-cm 2 wells. Following incubation for 24 h to establish maximal growth rates, the cultures were labeled for 6 h with 4 Ci/well [ 3 H]thymidine (15.5 Ci/mmol, DuPont NEN). Harvesting and quantitation of tritiated thymidine incorporation by triplicate cultures were performed using standard methodology.
Plasmid Construction; Transfection and Selection-A 2274-bp fragment of the rat 72-kDa Type IV collagenase cDNA (bp 25-1912 of the rat MMP-2 open reading frame and 387 bp of the immediate 3Ј-untranslated region) (Marti et al., 1993) was subcloned in an antisense orientation relative to the Rous sarcoma virus long terminal repeat of vector pRBK. pRBK is an episomally replicating expression vector containing the human papova virus BK origin of replication, the BK large T antigen, and a hygromycin resistance cassette. MC were transfected with the antisense MMP-2 construct (pRBK-AD), or with a control pRBK vector not containing an insert, using Lipofectin (Life Technologies, Inc.) as recommended by the manufacturer. After initial selection in 100 g/ml hygromycin B, resistant colonies were selected with cloning rings, expanded, and exposed in a stepwise fashion to increasing concentrations of hygromycin (up to 250 -500 g/ml). These resistant cultures were then subjected to two cycles of single cell cloning, of which six clones were chosen for further analysis. To verify transfection and replication of the episomal vector, low molecular weight extrachromosomal DNA from controls and transfected clones was prepared according to the method of Hirt (Hirt, 1967; DeBenedetti and Rhoads, 1991) and used to transform Escherichia coli XL-1 Blue to ampicillin resistance. Supercoiled plasmid added to Hirt extracts of untransfected cells was also used to transfect XL-1 Blue bacteria as a standard for determining episomal number.
The retroviral vector pLNCX (Miller et al., 1993) , was modified by the introduction of a linker, which placed unique ApaI, NotI, BglII, MluI, and HpaI restriction enzyme sites between the existing HindIII and ClaI sites. A hammerhead ribozyme cassette was created out of two overlapping 101-mer oligonucleotides terminating in NotI and MluI cohesive ends and ligated into the NotI and MluI sites of the modified pLNCX vector to create pLNCmx2. The ribozyme cassette contained two hammerhead ribozyme sequences designed to cleave GUC nucleotide motifs within the sequences located at 974 and 1994 of the rat MMP-2 cDNA. The ribozyme cassette contained the sequences GGGGAActgatgagtccgtgaggacgaaACACATGGG, hybridizing with the GUC at nt 974, and CAGAGGAGctgatgagtccgtgaggacgaaACAGAGCC, hybridizing with the GUC at nt 1994. In each case the uppercase nucleotides represent the inverse complement of the MMP-2 mRNA, while the nucleotides in lowercase represent the hammerhead ribozyme constant region. In vitro ribozyme activity was evaluated by preparing RNA transcripts of both the ribozyme cassette and a partial length MMP-2 containing the ribozyme target sites. In order to demonstrate ribozyme catalytic activity, synthetic T7 RNA polymerase (Ambion)-produced RNA transcripts of the ribozyme sequence were synthesized and incubated with synthetic, partial length (2200 nt) MMP-2 RNA transcripts synthesized in the presence of [ 32 P]CTP. After incubation as described by McCall et al. (1992) , RNA species were resolved on 6% polyacrylamide, 7 M urea gels and analyzed by autoradiography of the dried gels.
PA317 cells were transfected with the ribozyme vector by electroporation. The medium overlying these cells was collected at 24 and 48 h after transfection, 8 g/ml Polybrene was added and applied to subconfluent -2 cells. After 48 h 800 g/ml G418 was added and resistant clones selected and screened for virus production. Viral supernatants from the -2 producer cells were used to infect subconfluent mesangial cells at a low multiplicity of infection (Ϸ100 viruses/100-mm dish). Infected mesangial cells were subsequently selected in 800 g/ml G418. G418-resistant colonies were pooled without further subcloning.
Immunocytochemistry-Control MC and pRBK-AD clones were grown on etched coverslips. For staining of MMP-2 antigen, monensin (1 M) was added for the last 3 h of culture (Marti et al., 1994) . After fixation for 20 min with 4% paraformaldehyde, the cells were permeabilized with 0.1% Triton X-100, PBS and blocked with 5% goat serum in 0.1% bovine serum albumin in PBS. Cells were incubated with 5 g/ml affinity-purified rabbit anti-MMP-2 IgG as reported . For detection of extracellular matrix proteins, the cells were incubated with rabbit anti-human fibronectin (1 g of IgG/ml, Collaborative Biomedical Research), rabbit anti-mouse Type IV collagen (10 g of IgG/ml, Collaborative Biomedical Research), or rabbit anti-Type III collagen (2.5 g of IgG/ml, Chemicon). Biotinylated F(abЈ) 2 goatanti-rabbit IgG (5 g/ml, Zymed) was used as the secondary antibody, followed by incubation with either fluorescein-or rhodamine-conjugated streptavidin (Molecular Probes, Inc.). Mouse monoclonal anti-␣-smooth muscle actin (5 g/ml, Dako) was followed with biotinylated F(abЈ) 2 goat-anti-mouse IgG (5 g/ml) and streptavidin-fluorescein. A mouse monoclonal anti-statin IgG (2 g/ml) was kindly provided by Dr. Eugenia Wang, McGill University, Quebec, Canada. Mouse monoclonal anti-human PCNA (5 g/ml, Dako) was followed with biotinylated F(abЈ) 2 goat anti-mouse IgG and streptavidin-coupled horseradish peroxidase (Vector). Pre-embedding immunoelectron microscopy using the indirect horseradish peroxidase method was performed as reported in detail .
In Situ Reverse Transcription for Type IV ␣-1 Collagen mRNA-Control MC and a selected antisense subclone were grown on etched coverslips for 2 days in biotin-free RPMI medium supplemented with 10% dialyzed fetal calf serum. After fixation in 4% paraformaldehyde, cells were delipidated, rehydrated, permeabilized, and blocked with avidin/biotin solutions (Vector), as reported (Pollock and Lovett, 1992) . The cells were then prehybridized at 37°C for 30 min in hybridization solution containing 6 ϫ SSC, 25% deionized formamide, 1 ϫ Denhardt's solution, 200 g/ml yeast tRNA, and 100 g/ml salmon sperm DNA. For hybridization, 100 ng/ml Type IV ␣-1 collagen primer (murine sequence, nucleotides 582-606, 5Ј-CAACATCTCGCT-TCTCTCTATGGTG-3Ј) was applied in the same solution and incubated at 37°C for 18 h. After a stringency wash with 1 ϫ SSC at 55°C for 2 min, the slips were rinsed in reverse transcription buffer (50 mM Tris/ HCl, pH 8.0, 120 mM KCl, 10 mM MgCl 2 ). Reverse transcription was carried out for 2 h at 37°C with 200 units/ml avian myeloblastosis virus reverse transcriptase in the above buffer containing 7.5 mM DTT, 100 g/ml actinomycin-D, dCTP, dGTP, dTTP (600 M each), 50 M biotin-7-dATP, 0.01% (v/v) Triton X-100, and 100 units/ml placental ribonuclease inhibitor. Thereafter, the cells were washed briefly at 55°C with 0.1 ϫ SSC and then in PBS, before they were blocked for 30 min at 25°C with 3% rabbit serum in 0.1% bovine serum albumin, PBS. Incubation with 2.5 g/ml mouse anti-biotin IgG (Dako) for 1 h at 25°C was followed by incubation with biotinylated F(abЈ) 2 rabbit anti-mouse IgG (1 g/ml, Zymed) for 2 h, and finally with fluorescein-conjugated streptavidin at 10 g/ml. Controls included reverse transcriptions run without a specific primer, as well as sections pretreated with RNAse.
Enzymatic Reconstitution Experiments-MMP-2 in the latent form was purified to homogeneity from the conditioned medium of control MC according to the protocol of Okada et al. (1990) . Subconfluent cultures of control MC and an individual antisense clone with greater than 95% reduction in MMP-2 synthesis were rinsed twice with warm PBS and incubated in a serum-free growth medium (CHO-S-SFM, Life Technologies, Inc.), which supports MC growth. Purified MMP-2 was added in concentrations ranging from 10 nM to 1 M in either the latent or active form (generated by autocatalysis, confirmed by zymography). Controls were maintained in CHO medium alone. After 24 h all cultures were terminated by fixation. All experimental groups were evaluated by Giemsa staining for morphology, immunofluorescence staining for ␣-smooth muscle actin and immunoperoxidase staining for PCNA. To quantify MMP-2-dependent changes in cell phenotype, 6 random fields containing at least 100 cells each were evaluated by direct cell counting on duplicate coverslips.
An additional experiment to demonstrate the specificity of MMP-2 for MC phenotypic reconstitution was performed using the closely related enzyme, MMP-9 (92-kDa gelatinase B). COS 6 M cells were transiently transfected with the human MMP-9 cDNA (gift of Dr. B. Marmer, Washington University, St. Louis, MO) cloned into the expression vector pCDM8 (Invitrogen, San Diego, CA). Latent MMP-9 was purified to homogeneity from the conditioned culture medium by chromatography over gelatin-Sepharose and Lens culinaris lectin-agarose (McMillan et al., 1996) . MMP-9 was activated with 0.5 mM p-aminophenylmercuric acetate (confirmed by zymography), dialyzed against PBS, and added at a final concentration of 100 nM to control MC and antisense clones. Evaluation of MMP-9-treated cells was done as detailed above.
Evaluation of MT-MMP Synthesis-Poly(A)
ϩ RNA was prepared from MC_SF and MDA-MB231 cells by standard techniques. Double-stranded cDNA was prepared from this RNA using Superscript H Ϫ reverse transcriptase (Life Technologies, Inc.) according to the manufacturer's protocol. Both oligo(dT) and random hexamers were used to prime first strand synthesis. cDNAs were size selected by column chromatography to remove fragments Յ500 bp. Two ng of cDNA from either MC-SF or MDA-MB231 cells were used as template in a PCR reaction. The 5Ј primer was GGGAAACAAATACTGGAAATTCAAC (beginning at nt 1169 of human MT-MMP, nt 1226 of rat MT-MMP); the 3Ј primer contained the sequence GTTGAATTTCCAGTATTTGTTCCC (beginning 3Ј-5Ј at nt 1580 of human MT-MMP, nt 1633 of rat MT-MMP). PCR was performed by standard techniques using Taq polymerase and a Perkin-Elmer 9600 cycler repeating 38 cycles of a 30-s denaturation step at 92°C, a 30-s annealing step at 60°C, and a 30-s extension step at 72°C. This reaction amplified a 413-base pair product in which the rat sequence is 93% homologous to the corresponding human sequence. For analytical purposes the entire PCR reaction was electrophoresed on a 1.5% agarose gel. In order to prepare a probe for Northern analysis, 10 PCR reactions using the MDA-MB231 RNA as template were combined and resolved on 1% low melting temperature agarose gel. The 413-bp ethidium bromide-stained band was identified and excised, and the DNA recovered using ␤-agarase. Two g of poly(A) ϩ RNA from MDA-MB231 cells and 20 g of poly(A) ϩ RNA from MC-SF were electrophoresed in a 1% agarose, 2.2 M formaldehyde gel. RNA was capillary transferred to Hybond Nϩ and fixed according to the manufacturer's instructions. Twenty-five ng of the PCR-derived probe were labeled with [ 32 P]dCTP and hybridized overnight at 65°C in 6 ϫ SSC, 1% SDS, 100 g/ml sheared salmon sperm DNA, 10% dextran sulfate. The blot was washed at 55°C in 0.1 ϫ SSC, 1% SDS for 1 h and exposed to XAR film using two intensifying screens.
Zymographic analysis of MC_SF and MDA-MB231 plasma membrane fractions was performed to determine the presence or absence of actual MT-MMP enzymatic activity in these respective preparations. Plasma membrane-enriched fractions from each cell type were prepared and characterized as detailed (Lovett et al., 1987) . In addition, 50-g aliquots of membrane fractions were analyzed for the physical associations of MMP-2 and MT-MMP activities using: 1) salt extraction in 1 M potassium acetate, pH 8.0, for 15 min at 4°C; 2) acid stripping in 50 mM glycine, 0.1 M NaCl, pH 3.0, for 3 min at 4°C; and 3) detergent extraction in which membranes were incubated in 1% Triton X-114/PBS for 5 min at 4°C, centrifuged, and warmed to 37°C to permit phase separation. The Triton X-114 phase was recovered and analyzed by zymography.
Evaluation of MMP-2 Autocatalytic Activation-The kinetic and inhibition patterns of MMP-2 activation were compared using purified fluid phase MMP-2 and plasma membrane-associated enzyme. Sucrose density gradient purified MC_SF plasma membrane fractions were prepared as detailed above. Fifty-g aliquots of plasma membrane preparations, which contained 170 ng (0.25 nmol) of MMP-2 protein by quantitative assay, were incubated at 37°C for increasing time periods in 50 mM HEPES, pH 7.4, containing 5 mM phenylmethylsulfonyl fluoride. Thereafter, the materials were analyzed by gelatin zymography as detailed above. Parallel incubations were performed with the same concentration of purified fluid phase MMP-2, with subsequent zymographic analysis. The extent of conversion of the 72-kDa MMP-2 precursor to the 66-kDa activated form was quantified by densitometric analysis of the zymographic gels. Inhibition studies of the membraneassociated MMP-2 activation process were performed by the inclusion of 5 mM EDTA, 5 mM 1,10-phenanthrolene, or 5 g of recombinant human TIMP-1 (the gift of Dr. Gillian Murphy, Strangeways Research Laboratory, Cambridge, United Kingdom) in the incubation mixture, followed by zymographic analysis.
RESULTS
Cultured rat glomerular mesangial cells were subjected to sequential rounds of cloning to identify populations with high level, constitutive expression of a single matrix metalloproteinase, the 72-kDa gelatinase A (MMP-2). Constitutive secretion of the 72-kDa gelatinase enzyme into the culture medium from a selected MC clone, MC_SF, was 2.2 g/24 h/100 g of cellular protein, and this clone was similar to the other clones selected in all characteristics. In addition to high levels of secreted enzyme, these cells expressed large amounts of the enzyme on the cell surface. Quantitative determination of sucrose density gradient-prepared plasma membrane-enriched fractions revealed 340 ng of MMP-2/100 g of membrane protein. In both the case of the secreted and membrane-associated enzyme, greater than 95% of the MMP-2 was present in the latent form. Indirect immunoperoxidase electron microscopic analysis revealed a distinct pattern of mesangial cell surface MMP-2 staining, with prominent staining on the leading edges and extended filopodial processes (Fig. 1) .
Clone MC_SF was transfected with the episomally replicating pRBK vector, which contained the rat MMP-2 cDNA (bp 25-2299) in an antisense orientation (vector pRBK-AD). Controls included MC stably transfected with the pRBK vector alone (denoted MC-). Hygromycin-resistant colonies were subjected to stepwise increments in hygromycin concentration in order to maximize episome numbers, after which the colonies were further segregated by two rounds of single-cell cloning. Episomal replication of the antisense vector was verified by transfection of E. coli with low molecular weight Hirt DNA extracts of antisense clones and counting of ampicillin-resistant bacterial colonies. Simultaneous addition of pure supercoiled pRBK-AD plasmid DNA to Hirt extracts of untransfected cells were used as a standard to determine that highly suppressed antisense clones maintained greater than 500 episomal copies/cell. Supernatant levels of MMP-2 activity in multiple individual clones were measured and revealed suppression of the secreted enzyme ranging from 37% to greater than 95% (Fig. 6 ). Histochemical staining of these individual clones demonstrated a marked decrease in cell-associated MMP-2 antigen as compared to controls (Fig. 2, panels a and b) .
Analysis of the antisense-bearing clones revealed several distinguishing features. Control MC-cells exhibited the typical morphologic features of the activated mesangial phenotype (Bursten et al., 1991) , with elongation and prominent lamellopodia at the leading edges of these migratory cells. Directly corresponding with the immunoelectron microscopic studies, there was a notable concentration of MMP-2 staining along the bases of these lamellopodial extensions (Fig. 2, panel c) . In contrast, the highly suppressed MMP-2 antisense clones contained large numbers of rounded, non-motile cells, with minimal or no surface staining for the MMP-2 antigen (Fig. 2, panel  d) . Quantitative analysis of membrane MMP-2 activities confirmed the impressions given by immunofluorescence staining, with reductions to less than 14 ng/100 g of membrane protein.
The growth patterns of the highly suppressed MMP-2 antisense clones were distinctive when compared to the control MC-. Sparsely plated cultures of control MC-consisted of randomly distributed individual cells, with prominent elongation and minimal cellular contacts (Fig. 2, panel e) . The cells of the various MMP-2 antisense clones were considerably larger, rounded, and present in tight clusters evidencing multiple cellular contacts at all degrees of confluence (Fig. 2, panel f) .
The normally quiescent cells of the glomerular mesangium do not express the ␣ variant of smooth muscle cell actin; however, in a number of diseases characterized by mesangial proliferation, ␣-actin is synthesized at high levels by the intrinsic mesangial cells (Johnson et al., 1991; Elger et al., 1993) . Immunohistochemical staining of the rapidly proliferating control MC-demonstrated intense cellular staining for ␣-actin (Fig.  3, panel a) , consistent with the activated nature of these cells, while there was virtually no detectable ␣-actin within the MMP-2 antisense clones (Fig. 3, panel b) . This points to the return to a quiescent state, which occurs even in the continued presence of the growth stimulatory factors present in the culture medium.
The extracellular matrix protein synthetic profiles of cultured, proliferating rat MC have been extensively characterized and are typified by a preferential synthesis of interstitial collagens (Types I and III), minimal synthesis of Type IV collagen, and abundant cell surface-associated fibronectin (Ishimura et al., 1989; Doi et al., 1992; Haralson et al., 1987) . Consistent with these prior observations, control MC-cells exhibited pronounced cellular staining for the interstitial Type III collagen (Fig. 3, panel c) , with virtually no detectable Type IV collagen protein (Fig. 3, panel e) . The various MMP-2 antisense clones displayed the inverse of this staining pattern, with minimal expression of the Type III collagen (Fig. 3, panel d ) and bright cellular staining for Type IV collagen (Fig. 3, panel  f) . One potential explanation for the increased cellular staining for Type IV collagen protein in the MMP-2 antisense clones could be a nonspecific accumulation of this protein due to the elimination of its normal degradative enzyme, MMP-2, without changes in the intrinsic patterns of collagen gene expression and synthesis. However, in situ assessment of Type IV ␣1 collagen mRNA transcript abundance, using a recently described technique (Pollock and Lovett, 1992) , demonstrated that the increase in cellular Type IV ␣1 collagen protein in the MMP-2 antisense clones was directly associated with a major induction of the specific mRNA transcript. As shown in Fig. 3 (panel g), there was virtually no detectable Type IV ␣1 collagen mRNA in the MC-clones, while this transcript was abundantly expressed in the MMP-2 antisense clones (panel h). In contrast to the changes in collagen type gene expression, both control MC-and MMP-2 antisense clones synthesized large amounts of fibronectin. However, the patterns of fibronectin distribution differed radically. Control MC-exhibited intense cell surface staining, with no evidence for the formation of a fibrillar pericellular fibronectin matrix. On the other hand, the MMP-2 antisense clones were characterized by very dense pericellular arrays of fibronectin fibrils (Fig. 3, cf. panels i and j) . Such pericellular fibronectin fibrils are a common feature of fibronectin organization within the normal mesangium (Courtoy et al., 1980) .
To exclude the possibility that the induction of cellular quiescence by the antisense-expressing episomes was either a nonspecific consequence of the transfection procedure or of antisense RNA expression in general, an additional series of experiments were performed. For these studies the mesangial cells were infected with a retroviral vector, which expressed a hammerhead ribozyme sequence targeted against two distinct GUC sites within the rat MMP-2 cDNA sequence. Evaluation of the activity of the synthetic ribozyme against synthetic MMP-2 RNA in vitro indicated that the ribozyme was active in cleaving synthetic MMP-2 RNA (data not shown). MC_SF cells were infected with the pLNCmx2 retrovirus supernatants produced in -2 cells and more than 100 G418-resistant colonies were obtained. As summarized in Fig. 4 , ribozyme-mediated reduction in MMP-2 mRNA (greater than 8-fold; data not shown) led to a nearly total elimination of enzyme secretion as determined by gelatin zymography (panel A) or immunohistochemical staining (panels B and C). Ribozyme-mediated reduction in mesangial MMP-2 synthesis resulted in the assumption of all the quiescent phenotype features detailed above for the episomal vector, including minimal proliferative status, development of rounded, non-motile morphology (panels D, E) and loss of inflammatory matrix protein and ␣-actin expression (data not shown). It is important to note that the total pool of G418-resistant colonies recovered from the ribozyme-infected cells was used. In this way we demonstrate that the ribozyme mediated reduction in MMP-2 affected phenotype without raising questions of clonal bias.
The cell and colonial morphologies of the MMP-2 antisense cells are characteristic features of the normally quiescent mesangial cell in vivo and we therefore examined these cells for markers of cellular proliferative status. Virtually 100% of the rapidly growing control MC-cells stained positive for PCNA (Fig. 5, panel a) , a specific marker of cell proliferation (Celis et al., 1984; Kurki et al., 1988) . In contrast, fewer than 5% of an MMP-2 antisense clone (in which MMP-2 synthesis was suppressed up to 95%), stained positive for PCNA (Fig. 3, panel b) , verifying a markedly reduced proliferative rate. The effects of MMP-2 secretory inhibition on MC growth rates were not due to a nonspecific effect of the transfection procedure on progression through the cell cycle, as MMP-2 antisense clones exhibited a high level of specific nuclear envelope staining for statin (Connolly et al., 1988; Wang, 1989) , a 57-kDa protein marker of truly quiescent, G 0 cells (Fig. 5, cf. panels c and d) .
The degree of MMP-2 synthetic inhibition directly correlated with decreased MC proliferative rates, as determined by the quantitative measurement of MMP-2 enzyme activity and tritiated thymidine incorporation in multiple individual antisense clones (Fig. 6) . Examination of the resultant curve indicates that below a certain level of MMP-2 synthesis (0.5 g/24 h/100 g of cell protein), there is a nearly perfect log linear relationship between the growth rate and levels of MMP-2 synthesis.
Reconstitution experiments were performed in a serum-free growth medium with homogeneous preparations of either latent or active MMP-2 enzyme, in which antisense cells were exposed to increasing concentrations of MMP-2 for 24 h. Active MMP-2, in concentrations as low as 10 nM, restored the features of the inflammatory phenotype, including induction of proliferation, re-expression of ␣-actin and cellular elongation FIG. 3 . Expression of smooth muscle ␣-actin and ECM proteins. MC in culture stain intensively for smooth muscle ␣-actin (a), while there is virtually no ␣-actin detectable in MMP-2 antisense clones (b). The ECM protein synthetic profile reverted from high expression of Type III collagen (c) and minimal amounts of Type IV collagen (e) in controls to minimal expression of Type III collagen (d) and bright cellular staining for Type IV collagen (f) in MMP-2 antisense clones. In situ assessment of Type IV ␣1 mRNA abundance demonstrates that the increase in cellular Type IV ␣1 collagen protein in MMP-2 antisense clones is associated with an induction of the specific mRNA transcripts (g, control; h, antisense clone). The fibronectin distribution pattern shifts from the cell surface in control cells (i) to dense pericellular arrays of fibronectin fibrils in MMP-2 antisense clones (j). Final magnification, ϫ700.
with migration (Figs. 7 and 8) . The restoration of ␣-actin expression and cellular elongation by exposure to 10 nM active MMP-2 is detailed in Fig. 8 , which demonstrates an activated cluster of ␣-actin-positive, elongated cells within a background of rounded, actin-negative quiescent cells. Notably, latent MMP-2 in the same concentrations did not significantly affect the phenotypic features of the antisense cells (Fig. 7) . Further studies compared the activating function of MMP-2 with those of a closely related enzyme, MMP-9 (92-kDa gelatinase B), which has recently been demonstrated as a secretory product of cultured human mesangial cells (Martin et al., 1994) . In contrast to MMP-2, activated MMP-9 in concentrations of up to 100 nM did not result in restoration of the inflammatory phenotype (Fig. 7) .
The requirement for active, as opposed to latent, MMP-2 enzyme for the reconstitution of the inflammatory phenotype raised the issue of the potential mechanism(s) whereby the mesangial cell could facilitate the activation process. Recently, Strongin et al. (1995) described a plasma membrane-dependent MMP-2 activation process mediated by the formation of a trimolecular complex of MMP-2⅐TIMP-2 with a newly described intrinsic membrane matrix metalloproteinase denoted MT-MMP (Sato et al., 1994) . Using the breast carcinoma cell line MDA-MB231 as a MT-MMP-expressing control (Azzam et al., 1993) , mesangial cells were examined at three levels for the potential expression of MT-MMP. These studies are summarized in Fig. 9 . Northern blot analysis (panel I) of 2 g of Autocatalysis has been proposed as an alternative mechanism for MMP-2 activation (Crabbe et al., 1993; Bergmann et al., 1995) . To investigate this potential mechanism, 50-g aliquots of MC plasma membrane-enriched fractions, which contained 170 ng (0.25 nmol) of MMP-2, were incubated for 2 h at 37°C in a 50-l volume of 50 mM HEPES, pH 7.4, containing 5 mM phenylmethylsulfonyl fluoride and compared to 170 ng/50 l of fluid phase MMP-2 for the extent of proenzyme conversion. These results are summarized in Fig. 10 (panel I) . Zymographic analysis of fluid phase MMP-2 incubated under these conditions revealed no detectable conversion of the latent proenzyme form (lanes A and B) . In contrast, there was an extensive conversion (70%) of the latent MMP-2 in the plasma membrane enriched fraction (lanes C and D) . The inclusion of 5 mM EDTA (lane E), 5 mM 1-10 phenanthrolene (lane F), or 5 g of recombinant human TIMP-1 (lane G) in the incubation mixture completely inhibited the membrane-dependent conversion process. This inhibitory profile indicates that the conversion process is mediated by a matrix metalloproteinase, namely MMP-2. The kinetic pattern of the membrane-dependent MMP-2 activation process is detailed in Fig. 10 (panel II) and demonstrates a nonlinear, sigmoidal conversion process consistent with intermolecular autocatalytic MMP-2 processing. A log-logit plot of the time course of activation demonstrated a slope of 2.1 consistent with cooperativity.
DISCUSSION
Cultured mesangial cells accurately recapitulate the inflammatory and ECM synthetic profiles observed in both experimental and human glomerular disease Johnson et al., 1991; Elger et al., 1993; Ishimura et al., 1989; Doi et al., 1992; Haralson et al., 1987; Funabiki et al., 1990; Oomura et al., 1989; Yoshioka et al., 1989; Floege et al., 1992) , and represent a useful model system to assess various potential therapeutic approaches to revert the mesangial phenotype to normal. Because multiple enzymatic activities, including MMPs and the serine proteases plasminogen activator and plasmin, can affect ECM degradation, we isolated MC lines characterized by the synthesis of a single matrix-degrading enzyme, MMP-2. The critical role of this enzyme in the development or maintenance of the inflammatory phenotype was demonstrated by the antisense inhibition experiments, in which reversion to the quiescent phenotype occurred. This conclusion is further supported by the reconstitution experiments, whereby the features of the inflammatory phenotype could be restored by exposure to active, but not latent, MMP-2. The latter indicates that proteolytic activity is an essential compo- The incubations were performed as given above, but the reactions were stopped at increasing time points. The extent of MMP-2 activation was determined by densitometric analysis of zymographic gels. nent of the means by which MMP-2 regulates the cellular phenotype.
In this report, antisense inhibition strategies employed either an episomally replicating plasmid vector producing antisense MMP-2 RNA, or sequence-specific ribozymes transcribed by retroviral vectors to virtually eliminate the constitutive high level expression of MMP-2 by cultured rat glomerular mesangial cells. In order to assure that the effects of the high copy number episomal plasmid and the large antisense RNA were neither nonspecific or a result of an unintended antisense target, we used sequence-specific ribozymes expressed by a singlecopy retroviral vector. We note that both strategies were effective in reducing MMP-2 protein and in producing the same range of biologic effects in MC. This and the direct relationship between cell proliferation rates and the degree of MMP-2 synthetic inhibition strongly suggests that the effects described in this report can be specifically attributed to MMP-2.
The requirement for active MMP-2 in the expression of the inflammatory phenotype prompted an investigation of the cellular mechanisms which control this critical step. The interaction of a recently described intrinsic membrane matrix metalloproteinase, MT-MMP, with a MMP-2⅐TIMP-2 complex has been demonstrated to facilitate proteolytic conversion of latent MMP-2 to the active form (Strongin et al., 1995) . Alternatively, it has been proposed that MMP-2 activation can occur by purely autocatalytic means, a process that is facilitated by either high ambient concentrations or binding to cell surface polyanionic molecules (Bergmann et al., 1995; Crabbe et al., 1993) . Extensive analysis of the mesangial cells used in this study failed to demonstrate the presence or either MT-MMP transcripts or enzymatic activity in isolated plasma membrane fractions. In contrast, isolated mesangial cell plasma membrane preparations contained significant quantities of MMP-2 protein, which we demonstrate can be activated by an autocatalytic mechanism. As shown at both the light and electron microscopic levels in this report, the MMP-2 antigen is asymmetrically distributed upon the cell surface, with major concentrations of the enzyme found along the lamellopodial and filopodial processes. These highly concentrated foci of MMP-2 may serve both to localize the enzyme to sites of pericellular proteolysis and to facilitate the autocatalytic process. As we have been unable to demonstrate classical high affinity MMP-2 binding sites on mesangial cell membranes, 2 it is likely that this interaction is mediated by a charge-dependent mechanism similar to that postulated by Crabbe et al. (1993) . The salt and acid extraction studies detailed in this report are also supportive of such a relationship.
The more extensively studied serine proteases, including plasminogen activator (urokinase) and thrombin, may provide some mechanistic insights into the means by which MMP-2 inhibition results in loss of the mesangial inflammatory phenotype. Scher has argued that serine proteases should be considered as bona fide growth factors, with direct effects upon cellular growth and differentiation (Scher, 1987) . Both thrombin and urokinase are mitogenic for cultured cells, and regulated expression of urokinase has been shown to be essential for several normal developmental processes, including vascular morphogenesis (McNamara et al., 1993; Kirchheimer et al., 1987; Montesano et al., 1990) . Urokinase and thrombin exert their effects via specific cell surface receptors, and the concentration of urokinase receptors to the leading edges of cells appears essential for migratory ability (Pepper et al., 1993) . In a study bearing considerable parallels to the present one, antisense inhibition of a cell surface serine protease, myeloblastin, induced growth arrest, and differentiation of myelocytic leukemia cells (Bories et al., 1989) .
The requirement for protease activity in these studies bears a close resemblance to the need for active MMP-2 in order to reconstitute the inflammatory phenotype. Notably, the closely related metalloproteinase, MMP-9, was not effective in reconstituting the inflammatory phenotype. While similar in many respects, the precise substrate specificities of MMP-2 and 9 are distinct (Morodomi et al., 1992; Okada et al., 1990 Okada et al., , 1992 . For example, MMP-9 has a higher degree of activity than MMP-2 for Types IV and V collagens. In contrast, MMP-2, but not MMP-9, can degrade fibronectin and laminin. Significantly, a direct relationship between the presence of fibronectin-degrading surface proteases and the ability of cells to proliferate and migrate has been demonstrated (Chen and Chen, 1987) . Conversely, maneuvers that facilitate fibronectin pericellular matrix assembly, including protease inhibition or overexpression of fibronectin integrin receptors, result in a loss of cell motility and invasive properties (Giancotti and Ruoslahti, 1990; Juliano and Haskill, 1993) . These observations, coupled with the requirement for proteolytic activity, suggest that the specific action of MMP-2 is the result of cleavage of certain extracellular matrix proteins, such as fibronectin, which are not affected by MMP-9.
Given the above considerations, we propose that the MMP-2 enzyme is synthesized as a consequence of mesangial cell activation and is concentrated to sites immediately involved in the limited proteolysis of critical ECM proteins. The subsequent transition to an inflammatory phenotype may be the result of changes in ECM-integrin receptor interactions or ability to respond to ambient growth factors (Juliano and Haskill, 1993) . The further analysis of these issues may be expected to provide additional insights into these critical processes and could conceivably lead to novel approaches to the therapy of multiple inflammatory diseases, including those affecting the glomerulus.
